Trademark: 88096818
Status Date
Tuesday, February 16, 2021
Filing Date
Wednesday, August 29, 2018
Published for Opposition
Tuesday, February 19, 2019
Abandoned Date
Thursday, February 4, 2021
42 Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Software as a service (SAAS) services featuring software for precision oncology drug library screening; Product research and development, namely, testing of the newest drugs through high-throughput smart-screening platform to determine the best pharmacological treatments for an individual patient; Pharmacological product research consultation services that will enable others, namely, doctors and clinicians, to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing
44 Medical testing for diagnostic or treatment purposes; Providing cancer screening services; Genetic counseling; Genetic testing for medical purposes; Health care services for treating cancer; Medical analysis services for the diagnosis of cancer; Providing personalized healthcare and medical information in the nature of providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing, individual behaviors including medication compliance, exercise, diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis
Feb 16, 2021
Abandonment Notice E-Mailed - Failure To Respond
Feb 16, 2021
Abandonment - Failure To Respond Or Late Response
Aug 3, 2020
Notification Of Final Refusal Emailed
Aug 3, 2020
Final Refusal E-Mailed
Aug 3, 2020
Su - Final Refusal - Written
Jul 29, 2020
Teas/Email Correspondence Entered
Jul 28, 2020
Correspondence Received In Law Office
Jul 28, 2020
Teas Response To Office Action Received
Apr 28, 2020
Notification Of Non-Final Action E-Mailed
Apr 28, 2020
Non-Final Action E-Mailed
Apr 28, 2020
Su - Non-Final Action - Written
Apr 9, 2020
Statement Of Use Processing Complete
Mar 24, 2020
Use Amendment Filed
Apr 9, 2020
Case Assigned To Intent To Use Paralegal
Mar 24, 2020
Teas Statement Of Use Received
Aug 28, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 26, 2019
Extension 1 Granted
Aug 26, 2019
Extension 1 Filed
Aug 26, 2019
Teas Extension Received
Apr 16, 2019
Noa E-Mailed - Sou Required From Applicant
Feb 19, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 19, 2019
Published For Opposition
Jan 30, 2019
Notification Of Notice Of Publication E-Mailed
Jan 11, 2019
Assigned To Lie
Dec 18, 2018
Approved For Pub - Principal Register
Dec 17, 2018
Teas/Email Correspondence Entered
Dec 17, 2018
Correspondence Received In Law Office
Dec 17, 2018
Teas Response To Office Action Received
Dec 12, 2018
Notification Of Priority Action E-Mailed
Dec 12, 2018
Priority Action E-Mailed
Dec 12, 2018
Priority Action Written
Dec 12, 2018
Assigned To Examiner
Sep 7, 2018
New Application Office Supplied Data Entered In Tram
Sep 1, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
